Interestingly, the only patient with complete recovery of renal function even without C5 complement inhibitor therapy (patient 3) was also the only one who presented with a very short history: he had symptoms of COVID-19 ten days prior to presentation with TMA and admission to our center. The gene discussed is C5; the disease is COVID-19.